CUPRINA HOLDINGS (CAYMAN) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • September 3rd, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations • New York
The undersigned, Cuprina Holdings (Cayman) Limited, a Cayman Islands exempted company, (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters named in Schedule A hereto (such underwriters including Representative (as defined below), collectively, hereafter referred to as the “Underwriters”, and each of them as an “Underwriter”), for which Network 1 Financial Securities, Inc. acting as the representative of the several Underwriters (in such capacity, the “Representative”), to issue and sell an aggregate of [●] Class A ordinary shares (the “Firm Shares”) of the Company of par value of $0.001 per share (the “Class A Ordinary Shares”).
INDUSTRY RESEARCH COLLABORATION AGREEMENT RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • November 24th, 2023 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations
DATED THIS 3rd DAY OF JUNE 2022 Between NANYANG TECHNOLOGICAL UNIVERSITY – NTUITIVE PTE LTD And CUPRINA PTE LTD LICENSE AGREEMENT NTU CONFIDENTIALLicense Agreement • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations
NOW THEREFORE in consideration of the mutual promises set forth herein and rights obtained thereby, NTUitive and Licensee agree as follows.
Class A Ordinary Shares Purchase Warrant CUPRINA HOLDINGS (CAYMAN) LIMITEDPurchase Warrant Agreement • September 3rd, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations • New York
THIS CLASS A ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Network 1 Financial Securities, Inc. or its assigns (the “Holder”) are entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2024, the date that is 180 days after the commencement of sales under the Registration Statement (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (Eastern Time) on [●], the date that is five (5) years after the commencement of sales under the Registration Statement (the “Termination Date”) but not thereafter, in compliance with FINRA Rule 5110(e)(1) and FINRA Rule 5110(g)(8)(A), to subscribe for and purchase from Cuprina Holdings (Cayman) Limited , a Cayman Islands exempted company with limited liability (the “Company”), up to [●] Class A Ordinary Shares (as defined below) (as subject to adjustment hereunder, the “Warrant Shares”). The Warrant and the underlying Warrant Sha
INDUSTRY RESEARCH COLLABORATION AGREEMENT RESEARCH COLLABORATION AGREEMENTResearch and Development • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations
CUPRINA HOLDINGS (CAYMAN) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations • New York
The undersigned, Cuprina Holdings (Cayman) Limited, a Cayman Islands exempted company, (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters named in Schedule A hereto (such underwriters including Representative (as defined below), collectively, hereafter referred to as the “Underwriters”, and each of them as an “Underwriter”), for which Network 1 Financial Securities, Inc. acting as the representative of the several Underwriters (in such capacity, the “Representative”), to issue and sell an aggregate of [●] Class A ordinary shares (the “Firm Shares”) of the Company of par value of $0.001 per share (the “Class A Ordinary Shares”).
Class A Ordinary Shares Purchase Warrant CUPRINA HOLDINGS (CAYMAN) LIMITEDPurchase Warrant Agreement • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations • New York
THIS CLASS A ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Network 1 Financial Securities, Inc. or its assigns (the “Holder”) are entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 202_, the date that is 180 days after the commencement of sales under the Registration Statement (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (Eastern Time) on [●], the date that is five (5) years after the commencement of sales under the Registration Statement (the “Termination Date”) but not thereafter, in compliance with FINRA Rule 5110(e)(1) and FINRA Rule 5110(g)(8)(A), to subscribe for and purchase from Cuprina Holdings (Cayman) Limited , a Cayman Islands exempted company with limited liability (the “Company”), up to [●] Class A Ordinary Shares (as defined below) (as subject to adjustment hereunder, the “Warrant Shares”). The Warrant and the underlying Warrant Sha
EMPLOYMENT AGREEMENTEmployment Agreement • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into this ______, (the “Effective Date”), by and between Cuprina Holdings (Cayman) Limited, a company incorporated and existing under the laws of the Cayman Islands (the “Company” and, together with all of its direct or indirect subsidiaries, collectively referred to as the “Company Group”), and ____, an individual (the “Executive”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations • New York
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of ____________, ____, by and between Cuprina Holdings (Cayman) Limited, an exempted company duly incorporated and validly existing under the law of the Cayman Islands (the “Company”), and _____________ (the “Indemnitee”), a director of the Company.
THIS AGREEMENT is made this 26th day of January 2023Partnership Agreement • December 6th, 2024 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations
